stockrowKoninklijke Philips N.V.
PHG Healthcare Medical Devices
Koninklijke Philips N.V.’s revenue for fiscal 2025 (year ended December 2025) was $20.2 billion, up 3.47% from fiscal 2024.
- Revenue
- +0.55%
- EPS
- −85.0%
- Free cash flow
- +154.2%
- Total debt
- −4.96%
Quarter to September 2026, against a year earlier
Follow PHG
Alert me
Koninklijke Philips N.V. (PHG) Net income
Koninklijke Philips N.V.'s net income for fiscal 2025 was $1.0B, compared with −$755.3M in fiscal 2024. Over the twelve months to 30 September 2026 it was $1.1B. Over the past ten years it has ranged from −$1.7B (fiscal 2022) to $3.9B (fiscal 2021); the current reading is higher than 45% of that period. Koninklijke Philips N.V. ranks 7th of 149 Medical Devices companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | $1.0B | — |
| FY2024 | −$755.3M | — |
| FY2023 | −$501.1M | — |
| FY2022 | −$1.7B | — |
| FY2021 | $3.9B | 188.01% |
| FY2020 | $1.4B | 3.90% |
| FY2019 | $1.3B | 1.41% |
| FY2018 | $1.3B | (38.71%) |
| FY2017 | $2.1B | 28.11% |
| FY2016 | $1.6B | 125.48% |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Sep 2026 | $26.0M | (94.19%) |
| Jun 2026 | $447.7M | 161.99% |
| Mar 2026 | $170.9M | (60.41%) |
| Dec 2025 | $431.6M | 88.38% |
| 36 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| BSX Boston Scientific Corporation compare | $3.5B |
| GEHC GE HealthCare Technologies Inc. compare | $2.2B |
| SNN Smith & Nephew SNATS, Inc. compare | $2.0B |
| PHG Koninklijke Philips N.V. | $1.1B |
| EW Edwards Lifesciences Corporation compare | $1.0B |
| DXCM DexCom, Inc. compare | $991.0M |
| STE STERIS plc compare | $829.8M |
| ZBH Zimmer Biomet Holdings, Inc. compare | $768.8M |
| GKOS Glaukos Corporation compare | −$169.8M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on PHG
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement